Literature DB >> 25962475

Diagnosing domoic acid toxicosis in the California sea lion (Zalophus californianus) using behavioral criteria: A novel approach.

Christiana Wittmaack1, Garet P Lahvis2, Edward O Keith1, Caryn Self-Sullivan1.   

Abstract

Domoic acid toxicosis in the California sea lion (Zalophus californianus) is difficult to diagnose using presence of toxin alone because the duration of domoic acid presence in blood and urine is generally less than 48 hr following exposure. Because domoic acid toxicosis is often suggested by presentation of behavioral abnormalities, we asked whether assessment of behavior might be useful for diagnostic purposes. We developed an ethogram to categorize behavioral data collected via continuous focal animal sampling. In total, 169 subjects were observed at a rehabilitation center. Sea lions with domoic acid toxicosis displayed head weaving (P < 0.0001) and muscle fasciculations (P < 0.01) significantly more often than animals in a comparison group. Dragging hind flippers and swift scanning were observed exclusively in animals from the domoic acid toxicosis group. The data show that behavioral diagnostic criteria can be effective in the diagnosis of domoic acid toxicosis in the California sea lion.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  California sea lion; HABs; Pseudonitzschia; Zalophus californianus; behavior; diagnostics; domoic acid

Mesh:

Substances:

Year:  2015        PMID: 25962475     DOI: 10.1002/zoo.21217

Source DB:  PubMed          Journal:  Zoo Biol        ISSN: 0733-3188            Impact factor:   1.421


  2 in total

1.  Prenatal domoic acid exposure disrupts mouse pro-social behavior and functional connectivity MRI.

Authors:  Brian D Mills; Hadley L Pearce; Omar Khan; Ben R Jarrett; Damien A Fair; Garet P Lahvis
Journal:  Behav Brain Res       Date:  2016-04-02       Impact factor: 3.332

Review 2.  What California sea lions exposed to domoic acid might teach us about autism: lessons for predictive and preventive medicine.

Authors:  Garet Paul Lahvis
Journal:  EPMA J       Date:  2017-09-12       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.